Gene Solutions Establishes Global Market Footprint with Pioneering MCED and MRD Tests in CAP-Accredited Laboratory

Gene Solutions Group proudly announces that our Next-Generation Sequencing laboratory in Singapore has been awarded College of American Pathologists (CAP) accreditation. This honor, granted after a rigorous on-site evaluation, provides recognition of the clinical utility of our circulating tumor DNA (ctDNA) tests, specifically in Multi-Cancer Early Detection (MCED) and Minimal Residual Disease (MRD) monitoring. These